Safety Profile and Clinical Activity of Multiple Subcutaneous Doses of MEDI-528, a Humanized Anti-Interleukin-9 Monoclonal Antibody, in Two Randomized Phase 2a Studies in Subjects With Asthma
BMC Pulmonary Medicine - United Kingdom
doi 10.1186/1471-2466-11-14
Full Text
Open PDFAbstract
Available in full text
Date
February 28, 2011
Authors
Publisher
Springer Science and Business Media LLC